Thermo Fisher Scientific Targets Neurons And Primary Cells With Expansion Of Transfection Reagent Portfolio

CARLSBAD, Calif.--(BUSINESS WIRE)--Researchers can now more efficiently study predictive cell models and human disease with the launch of a new high-efficiency transfection reagent for mRNA delivery in neurons and primary cell types.

Lipofectamine MessengerMAX offers up to a five times the efficiency of DNA reagents and enables researchers to easily transfect biologically relevant cell models without electroporation or viruses. Researchers studying these cells have been faced with challenges due to limited options in the market. DNA reagents tend to be inefficient for transfection of primary cells, and other approaches can introduce toxicity into cells and negatively affect data.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC